- Neue Therapie bei Patienten mit chronischer lymphatischer LeukämieB., Eichhorst; S., NitschmannDer Internist, 2020, 61(7): 770-772.
- Efficacy and Safety of Chimeric Antigen Receptor T Cells Therapy Combined with Zanubrutinib in the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaWang, Langqi; Yang, Jilong; Jin, Bo; Wang, Bo; Zhou, Lijuan; Zhuo, Yaqi; Chen, Huifang; Chang, Lung-Ji; Tu, Sanfang; Li, Yuhua65th Annual Meeting of the American-Society-of-Hematology (ASH), San Diego, CA, 2023-12-09 To 2023-12-12.
- MIP3α As an Early Prognostic Predictor for Patients with B-Cell Malignancies Receiving CD19/CD22-Redirected CAR T-Cell Cocktail TherapyJin, Jin; Cheng, Jiali; Wang, Na; Huang, Liang; Zhou, Xiaoxi; Chen, Liting; Luo, Hui; Liu, Tianjiao; Meng, Jiao64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), New Orleans, LA, 2022-12-10 To 2022-12-13.
期刊论文
Novel Pharmacotherapies for B-Cell Lymphomas and Leukemias
10阅读
